15-Mar-2010 - Roche Diagnostics GmbH

Roche Diagnostics Purchases Microarray Instrument and Accessory Assets from BioMicro Systems

Roche Diagnostics has purchased assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow. These assets consist of key instrumentation in the Roche NimbleGen microarray workflow. Also included in this purchase are array accessories covering all mixers designed for the Roche NimbleGen high-density microarray portfolio. Roche Diagnostics will continue to provide global sales, service, and support for all products in the NimbleGen microarray workflows.

With the purchase of these assets, Roche Diagnostics will transfer the manufacturing capabilities for the above products to an in-house manufacturing facility. According to Andreas Görtz, VP of Marketing at Roche NimbleGen, ‘The acquired products are integral to the high quality data the NimbleGen array workflow provides researchers worldwide. Acquiring these assets will allow Roche complete control over the production, support and service of these products to ensure continued timely distribution, full support and the high level of service our customers have grown to expect from Roche.”

Facts, background information, dossiers
  • BioMicro Systems
More about Roche Diagnostics
More about Roche
  • News

    Start-up Inflazome Announces Acquisition by Roche

    Inflazome announced that it has closed a share purchase agreement with Roche  in which Inflazome’s shareholders received an upfront payment of €380 million, and are eligible to receive additional contingent payments to be made based on the achievement of certain predetermined milestones.  I ... more

    Roche acquires Stratos Genomics

    Roche announced that it has acquired Stratos Genomics, an early-stage sequencing technology company to advance the development of Roche’s nanopore sequencer. The acquisition provides Roche access to Stratos Genomics unique chemistry, Sequencing by Expansion (SBX™). The Roche nanopore sequen ... more

    Roche initiates Phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia

    Roche announced that it are working with the Food & Drug Administration (FDA) to initiate a randomised, double-blind, placebo-controlled Phase III clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), a part of the US Health and Human Servi ... more

  • Companies

    Roche Austria GmbH

    Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche i ... more

    Roche Deutschland Holding GmbH


More about BioMicro Systems
  • Companies

    BioMicro Systems, Inc.

    BioMicro® Systems, Inc. is a private company founded in 2000 with expertise in microfluidics. BioMicro Systems is focused on the development and commercialization of biological research products based on its proprietary microfluidic handling technologies. more